연구성과로 돌아가기

2023 연구자 정보 (138 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Yoo, Byung Wook
(Yoo, BW) ⓘ 		Soon Chun Hyang Univ Hosp, Dept Family Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.4] Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03 interim results of a randomised, active-controlled, observer-blinded, phase 3 trial ⓘ SCIE ⓘ 4.4 MEDICINE, GENERAL & INTERNAL ⓘ heejinmd@korea.ac.kr; ⓘ
Yoo, Kyung Don
(Yoo, KD) ⓘ 		Univ Ulsan, Ulsan, South Korea
Ulsan Univ Hosp, Ulsan, South Korea
Ulsan Univ Hosp, Internal Med, Ulsan, South Korea
Univ Ulsan, Ulsan Univ Hosp, Dept Internal Med, Div Nephrol,Coll Med, 25 Daehakbyeongwon Ro, Ulsan 44030, South Korea
Univ Ulsan, Basic Clin Convergence Res Inst, 25 Daehakbyeongwon Ro, Ulsan 44030, South Korea
Univ Ulsan, Coll Med, Ulsan, South Korea
Univ Ulsan, Ulsan Univ Hosp, Dept Internal Med, Div Nephrol,Coll Med, Ulsan, South Korea ⓘ 		AAK-8096-2020
Yoo, Kyung ⓘ
ⓘ 		[JCR상위 4.4] Cancer Status and Mortality in Older Hemodialysis Patients: Data from a Korean Society of Geriatric Nephrology Retrospective Cohort
[JCR상위 4.4] Association of Dementia Diagnosis at Dialysis Initiation with Mortality in the Elderly ESKD Population in South Korea
[JCR상위 11.5] CANCER STATUS AND MORTALITY IN ELDERLY INCIDENT HEMODIALYSIS PATIENTS
[JCR상위 43.3] Effect of low-density lipoprotein level and mortality in older incident statin-naive hemodialysis patients
[JCR상위 4.4] The Current Status of Advance Care Plan and Dialysis Withdrawal in Elderly Hemodialysis Patients in South Korea
[JCR상위 18.3] Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach ⓘ 		SCIE ⓘ 4.4 UROLOGY & NEPHROLOGY
TRANSPLANTATION;UROLOGY & NEPHROLOGY
MULTIDISCIPLINARY SCIENCES ⓘ 		hkim@schmc.ac.kr;ykd9062@gmail.com;
nephrolee@gmail.com; ⓘ
Yook, Ju-Min
(Yook, JM) ⓘ 		Kyungpook Natl Univ Hosp, Daegu, South Korea
Kyungpook Natl Univ Hosp, Div Nephrol, Dept Internal Med, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.4] High-Fat Diet Changes Lipid Profiles and Induces Podocyte Injury in Unilateral Kidney Model: Targeted Lipidomic and Kidney Podocyte-Specific Analysis
[JCR상위 18.3] In vivo imaging of renal microvasculature in a murine ischemia-reperfusion injury model using optical coherence tomography angiography ⓘ 		SCIE ⓘ 4.4 UROLOGY & NEPHROLOGY
MULTIDISCIPLINARY SCIENCES ⓘ 		jh-cho@knu.ac.kr;woh1@kaist.ac.kr; ⓘ
Abramov, Frida
(Abramov, F) ⓘ 		Gilead Sci Inc, Foster City, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Anderson, Katie
(Anderson, K) ⓘ 		Vaccitech Plc, Immunol Res, Oxford, England ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Baek, Yang Hyun
(Baek, YH) ⓘ 		Dong A Univ, Coll Med, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] PROPOSAL OF A NOVEL SEROLOGICAL ALGORITHM COMBINING A FIBROSIS INDEX BASED ON FOUR AND SERUM MAC-2 BINDING PROTEIN GLYCOSYLATION ISOMER FOR ADVANCED FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE
[JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY ⓘ 		SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Barnes, Eleanor
(Barnes, E) ⓘ 		Univ Oxford, Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England
Univ Oxford, Nuffield Dept Med, Oxford, England ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Bezerra, Jorge A.
(Bezerra, JA) ⓘ 		Univ Texas Southwestern Med Ctr, Dallas, TX USA ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Bin Lee, Yun
(Bin Lee, Y) ⓘ 		Seoul Natl Univ Hosp, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Bouquet, Jerome
(Bouquet, J) ⓘ 		GSK, San Francisco, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Brown, Anthony
(Brown, A) ⓘ 		Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Bussey, Louise
(Bussey, L) ⓘ 		Vaccitech, Clin Operat, Oxford, England ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Chang, Mei Hwei
(Chang, MH) ⓘ 		Natl Taiwan Univ, Taipei, Taiwan
Children Hosp, Taipei, Taiwan ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) ⓘ SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Chen, Chi-Yi
(Chen, CY) ⓘ 		Chia Yi Christian Hosp, Chiayi, Taiwan
Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Hepatogastroenterol, Chiayi, Taiwan ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES
[JCR상위 8.7] Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study ⓘ 		SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ mhhur@snu.ac.kr;alsrud627@snu.ac.kr;terryfungyip@gmail.com;e580306@ms31.hinet.net;vital@snu.ac.kr;dr.choi85@gmail.com;KSUKOREA@yuhs.ac;limys@amc.seoul.kr;psyoung0419@gmail.com;wonglaihung@mect.cuhk.edu.hk;sinndhn@gmail.com;jyj412@hanmail.net;sekim@hallym.or.kr;cypeng@mail.cmuh.org.tw;drshp@khu.ac.kr;5137ccy@gmail.com;hwiyoung@gmail.com;amelia86@naver.com;gandorie@gmail.com;noshin@hanyang.ac.kr;mseileen80@hanyang.ac.kr;sonjh@hanyang.ac.kr;dr486@eulji.ac.kr;jshim3927@gmail.com;jeongsw@schmc.ac.kr;choyk2004.cho@samsung.com;hskim@kdh.or.kr;mjjang2014@naver.com;yoonjun@snu.ac.kr;yoonjh@snu.ac.kr;pindra@empal.com; ⓘ
Cho, Yong Kyun
(Cho, YK) ⓘ 		Sungkyunkwan Univ, Sch Med, Seoul, South Korea
Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR
[JCR상위 8.7] Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study ⓘ 		SCIE ⓘ 4.5 GASTROENTEROLOGY & HEPATOLOGY ⓘ mhhur@snu.ac.kr;alsrud627@snu.ac.kr;terryfungyip@gmail.com;e580306@ms31.hinet.net;vital@snu.ac.kr;dr.choi85@gmail.com;KSUKOREA@yuhs.ac;limys@amc.seoul.kr;psyoung0419@gmail.com;wonglaihung@mect.cuhk.edu.hk;sinndhn@gmail.com;jyj412@hanmail.net;sekim@hallym.or.kr;cypeng@mail.cmuh.org.tw;drshp@khu.ac.kr;5137ccy@gmail.com;hwiyoung@gmail.com;amelia86@naver.com;gandorie@gmail.com;noshin@hanyang.ac.kr;mseileen80@hanyang.ac.kr;sonjh@hanyang.ac.kr;dr486@eulji.ac.kr;jshim3927@gmail.com;jeongsw@schmc.ac.kr;choyk2004.cho@samsung.com;hskim@kdh.or.kr;mjjang2014@naver.com;yoonjun@snu.ac.kr;yoonjh@snu.ac.kr;pindra@empal.com; ⓘ
페이지 이동: